The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

By Shane Crotty, David Maag, Jamie J. Arnold, W. Zhong, J. Lau, Z. Hong, Raul Andino, C. Cameron. Nature Medicine, 2000

841 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Infectious Diseases, Plant Science

View Paper: https://www.semanticscholar.org/paper/b2706a110b1815793350215ea7d18b784d37a96c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. E. Snijder
2. J. Ziebuhr
3. Alexander E. Gorbalenya
4. Rolf Hilgenfeld
5. P. Masters

Citations in the corpus

• Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage (2003, background): “If confirmed, these unusual properties would explain the preliminary reports on the resistance of SARS-CoV to ribavirin, a drug that was shown to force other RNA viruses into “error catastrophe”.(56) The experimental verification of these predictions will be an important step in increasing our under”
• Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency (2020, neutral): “[ -32P]GTP was purchased from PerkinElmer Life Sciences.”